Oriflame has announced new scientific findings showing that its patented bioactivating technology, Oripeptide-3, significantly supports key biological drivers of skin ageing. Central to the NovAge+ range, the breakthrough underscores Oriflame’s two-decade-long research into cellular health, skin longevity, and anti-ageing science.
Developed to work with the skin’s natural biology, Oripeptide-3 targets five recognised hallmarks of ageing, including DNA protection, cellular renewal, protein quality maintenance, and boosting cellular energy for repair and defence. According to Oriflame’s Director of Scientific Research and Innovation, Dr Lene Visdal-Johnsen, the technology strengthens the foundation for healthier, more resilient, and youthful-looking skin. Edyta Kurek, Senior VP & Head of Oriflame India and Indonesia, highlighted that innovations like Oripeptide-3 reflect the brand’s commitment to long-term, molecular-level skin benefits.
The NovAge+ range has already seen growing traction, with local consumers showing keen interest in science-backed skincare. Retail outlets across the city, including major department stores and Oriflame partner boutiques, have reported increased footfall as awareness about skin longevity and Oripeptide-3 spreads. Oriflame, a leading Swedish holistic beauty brand present in over 60 countries, continues to strengthen its position in advanced skin biology, reinforcing its focus on innovation and sustainable wellbeing products for long-term skin health.